Description: Our mission is to empower collaborative and breakthrough research that advances our fundamental understanding of ALS by engaging and supporting the global
May is ALS Awareness Month May is ALS Awareness Month! Make a gift in May to support ALS Research FDA grants accelerated approval of tofersen for treatment of SOD1-ALS Drug’s development stemmed from collaborative research from Packard Center investigators. Read more: Artificial intelligence-driven platform identifies new ALS gene targets Twenty-eight targets were identified, and the collaborative study was led by Insilico with support from Answer ALS and researchers at nine institutions including the Johns
Understanding ALS
Meet the Packard Center Team